Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder

European Archives of Psychiatry and Clinical Neuroscience

Volumn 258, Issue 5, 2008, Pages 300-304

  Cunha, Ângelo B ^a   Andreazza, Ana C ^b,c   Gomes, Fabiano A ^c   Frey, Benicio N ^d   Da Silveira, Leonardo E ^c   Gonçalves, Carlos A ^b   Kapczinski, Flávio ^c  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Bipolar disorder; High sensitivity C reactive protein; Inflammation; Mania; Pathophysiology

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; CONTROLLED STUDY; EUTHYMIA; FEMALE; HUMAN; IMMUNE SYSTEM; INFLAMMATION; MALE; MOOD CHANGE; MOOD DISORDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AFFECT; BIPOLAR DISORDER; C-REACTIVE PROTEIN; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; LATEX FIXATION TESTS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES;

EID: 50249147789     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-007-0797-0     Document Type: Article

References (44)

1. Andreazza AC, Cassini C, Rosa AR, Leite MC, de Almeida LM, Nardin P, Cunha AB, Cereser KM, Santin A, Gottfried C, Salvador M, Kapczinski F, Gonçalves CA (2007) Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatry Res 41:523-529
2. Arcoleo F, Milano S, D'Agostino P, Misiano G, Cappelletti S, Gromo G, Marcucci F, Leoni F, Cillari E (1997) Effect of partially modified retro-inverso analogues derived from C-reactive protein on the induction of nitric oxide synthesis in peritoneal macrophages. Br J Pharmacol 120:1383-1389
3. Baptista T, Davila A, El Fakih Y, Uzcategui E, Rangel NN, Olivares Y, Galeazzi T, Vargas D, Pena R, Marquina D, Villarroel V, Teneud L, Beaulieu S (2007) Similar frequency of abnormal correlation between serum leptin levels and BMI before and after olanzapine treatment in schizophrenia. Int Clin Psychopharmacol 22:205-211
4. Belmaker RH (2004) Bipolar disorder. N Engl J Med 351:476-486
5. Carlson NG, Wieggel WA, Chen J, Bacchi A, Rogers SW, Gahring LC (1999) Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J Immunol 163:3963-3968
6. Cunha AB, Frey BN, Andreazza AC, Goi JD, Rosa AR, Goncalves CA, Santin A, Kapczinski F (2006) Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 398: 215-219
7. Ferranti SD de, Rifai N (2007) C-reactive protein: a nontraditional serum marker of cardiovascular risk. Cardiovasc Pathol 16:14-21
8. Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R (2007) Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 31:952-955
9. Dohi Y, Takase H, Sato K, Ueda R (2007) Association among C-reactive protein, oxidative stress, and traditional risk factors in healthy Japanese subjects. Int J Cardiol 115:63-66
10. Eda S, Kaufmann J, Roos W, Pohl S (1998) Development of a new microparticle-enhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range. J Clin Lab Anal 12:137-144
11. First MB, Spitzer RL, Gibbon M, Williams JB (1998) Structured clinical interview for DSM-IV (SCID-I). Biomedics Research Department, New York
12. Ford DE, Erlinger TP (2004) Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 164:1010-1014
13. Frey BN, Andreazza AC, Kunz M, Gomes FA, Quevedo J, Salvador M, Goncalves CA, Kapczinski F (2007) Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Progr Neuropsychopharmacol Biol Psychiatry 31:283-285
14. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
15. Hohlfeld R (2007) Does inflammation stimulate remyelination? J Neurol 254(Suppl 1):I47-I54
16. Hornig M, Goodman DB, Kamoun M, Amsterdam JD (1998) Positive and negative acute phase proteins in affective subtypes. J Affect Disord 49:9-18
17. Huang TL, Lin FC (2007) High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania. Progr Neuropsychopharmacol Biol Psychiatry 31:370-372
18. Ikeda U, Maeda Y, Yamamoto K, Shimada K (2002) C-reactive protein augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. Cardiovasc Res 56:86-92
19. Kim SH, Smith CJ, Van Eldik LJ (2004) Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1 beta production. Neurobiol Aging 25:431-439
20. Kim YK, Jung HG, Myint AM, Kim H, Park SH (2007) Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J. Affect Disord (in press)
21. Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, Sorond F (2005) Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 4:371-380
22. Kupfer DJ (2005) The increasing medical burden in bipolar disorder. JAMA 293:2528-2530
23. Legros S, Mendlewicz J, Wybran J (1985) Immunoglobulins, autoantibodies, other serum protein fractions in psychiatric disorders. Eur Arch Psychiatry Neurol Sci 235:9-11
24. Machado-Vieira R, Lara DR, Portela LV, Goncalves CA, Soares JC, Kapczinski F, Souza DO (2002) Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study. Eur Neuropsychopharmacol 12:269-272
25. Newcomer JW (2006) Medical risk in patients with bipolar disorder and schizophrenia. J Clin Psychiatry 67(Suppl 9):25-30
26. O'Brien SM, Scott LV, Dinan TG (2006) Antidepressant therapy and C-reactive protein levels. Br J Psychiatry 188:449-452
27. O'Brien SM, Scully P, Scott LV, Dinan TG (2006) Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord 90:263-267
28. Ortiz-Dominguez A, Hernandez ME, Berlanga C, Gutierrez-Mora D, Moreno J, Heinze G, Pavon L (2007) Immune variations in bipolar disorder: phasic differences. Bipolar Disord 9:596-602
29. Ozcan ME, Gulec M, Ozerol E, Polat R, Akyol O (2004) Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 19:89-95
30. Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, Wagh UV, Debsikdar VB, Mahadik SP (2003) Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 121:109-122
31. Ratnam S, Mookerjea S (1998) The regulation of superoxide generation and nitric oxide synthesis by C-reactive protein. Immunology 94:560-568
32. Rosa AR, Frey BN, Andreazza AC, Cereser KM, Cunha AB, Quevedo J, Santin A, Gottfried C, Goncalves CA, Vieta E, Kapczinski F (2006) Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci Lett 407:146-150
33. Savas HA, Gergerlioglu HS, Armutcu F, Herken H, Yilmaz HR, Kocoglu E, Selek S, Tutkun H, Zoroglu SS, Akyol O (2006) Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World J Biol Psychiatry 7:51-55
34. Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ (2002) Early inflammation and dementia: a 25-year follow-up of the Honolulu Asia Aging Study. Ann Neurol 52:168-174
35. Sen J, Belli A (2007) S100B in neuropathologic states: the CRP of the brain? J Neurosci Res 85:1373-1380
36. Sluzewska A, Sobieska M, Rybakowski JK (1997) Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression. Neuropsychobiology 35:123- 127
37. Suarez EC (2004) C-reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults. Psychosom Med 66:684-691
38. Sugano Y, Anzai T, Yoshikawa T, Satoh T, Iwanaga S, Hayashi T, Maekawa Y, Shimizu H, Yozu R, Ogawa S (2005) Serum C-reactive protein elevation predicts poor clinical outcome in patients with distal type acute aortic dissection: association with the occurrence of oxygenation impairment. Int J Cardiol 102:39-45
39. Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E (2003) Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 170:429-433
40. Wadee AA, Kuschke RH, Wood LA, Berk M, Ichim L, Maes M (2002) Serological observations in patients suffering from acute manic episodes. Hum Psychopharmacol 17:175-179
41. Walz JC, Andreazza AC, Frey BN, Cacilhas AA, Cereser KM, Cunha AB, Weyne F, Stertz L, Santin A, Goncalves CA, Kapczinski F (2007) Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder. Neurosci Lett 415:87-89
42. Yasojima K, Schwab C, McGeer EG, McGeer PL (2000) Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Res 887:80-89
43. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429-435
44. Zarate CA Jr, Tohen M, Land M, Cavanagh S (2000) Functional impairment and cognition in bipolar disorder. Psychiatr Q 71:309-329